Synapse Open Synapse
Biology

Isomorphic Labs president says all drugs will be AI-designed as first trials near a year-end target

R&D World · · 2 min read

Isomorphic Labs president Max Jaderberg says AI will design all future drugs. Its programs are preclinical, with first trials targeted by the end of 2026.

Latest from R&D World